Cargando…

Determining whether the effect of liraglutide on non‐alcoholic fatty liver disease depends on reductions in the body mass index

BACKGROUND AND AIM: Non‐alcoholic fatty liver disease (NAFLD) initially presents as steatosis, which can progress to non‐alcoholic steatohepatitis (NASH), and often presents clinically alongside metabolic syndromes. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are regularly utilized to trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiomi, Megumi, Tanaka, Yoichi, Takada, Tesshu, Otori, Katsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578289/ https://www.ncbi.nlm.nih.gov/pubmed/33102775 http://dx.doi.org/10.1002/jgh3.12384

Ejemplares similares

Pill Counting in the Determination of Factors Affecting Medication Adherence in Patients with Type 2 Diabetes: A Retrospective Observational Study
por: Shiomi, Megumi, et al.
Publicado: (2021)

Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon‐like peptide‐1 receptor agonists
por: Shiomi, Megumi, et al.
Publicado: (2018)

Clinical Pharmacy Education in Japan: Using Simulated Patients in Laboratory-Based Communication-Skills Training before Clinical Practice
por: Kubota, Rie, et al.
Publicado: (2018)

Whether age of menarche is influenced by body mass index and lipoproteins profile? a retrospective study
por: Farahmand, Maryam, et al.
Publicado: (2012)

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index
por: Margariti, Ekaterini, et al.
Publicado: (2012)

Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease
por: Abangah, Ghobad, et al.
Publicado: (2014)

Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2022)

Body mass index and severity of parkinsonism in multiple system atrophy
por: Suzuki, Ai, et al.
Publicado: (2017)

Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
por: Funada, Kei, et al.
Publicado: (2023)

The Apelin Receptor APJ in Hematopoietic Stem Cells/Progenitor Cells in the Early Stage of Non-Alcoholic Steatohepatitis
por: Ando, Wataru, et al.
Publicado: (2017)

Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
por: Chitnis, Abhishek S., et al.
Publicado: (2014)

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta‐analysis of the liraglutide phase III clinical trial programme
por: Montanya, E., et al.
Publicado: (2016)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease
por: Zhang, Zhongyong, et al.
Publicado: (2018)

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
por: Luo, Ying, et al.
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Relationship of Body Mass Index to Alcohol Consumption in College Freshmen
por: Nies, Mary A., et al.
Publicado: (2012)

Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Li, Nong, et al.
Publicado: (2022)

The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
por: Hu, Haofei, et al.
Publicado: (2022)

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial
por: Feng, Wen‐Huan, et al.
Publicado: (2018)

Body Mass Index and Mortality From Aortic Aneurysm and Dissection
por: Takada, Midori, et al.
Publicado: (2021)

Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial
por: Bensignor, Megan O., et al.
Publicado: (2021)

The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
por: Kuang, Maobin, et al.
Publicado: (2022)

Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
por: Wang, Mengyuan, et al.
Publicado: (2023)

Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
por: Patel, Sumaiya, et al.
Publicado: (2016)

Association between Alcohol Consumption and Body Mass Index in University Students
por: Booranasuksakul, Uraiporn, et al.
Publicado: (2019)

Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project
por: Torbator, Kader, et al.
Publicado: (2022)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2020)

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
por: Kumar, Ramesh, et al.
Publicado: (2013)

Smoking and γ-Glutamyltransferase: Opposite Interactions with Alcohol Consumption and Body Mass Index
por: Breitling, Lutz P., et al.
Publicado: (2010)

Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population
por: Fojas, Esphie Grace Fodra, et al.
Publicado: (2022)

Influences of Total Laparoscopic Hysterectomy According to Body Mass Index (Underweight, Normal Weight, Overweight, or Obese)
por: Otake, Akiko, et al.
Publicado: (2019)

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
por: Zhang, Shengkui, et al.
Publicado: (2022)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Four-Way Decomposition of Effect of Alcohol Consumption and Body Mass Index on Lipid Profile
por: Gao, Chaonan, et al.
Publicado: (2021)

Comparison of Body Composition and Body Mass Index in the Determination of Obesity in Schoolchildren
por: Salman, Hakan, et al.
Publicado: (2022)

Higher Body Mass Index and Increased Prevalence of Paranasal Sinus Disease
por: Kabeya, Yusuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3ji1k30vp3m3th60d4aoko8hap